David Kreimer active positions
| Companies | Position | Start | End |
|---|---|---|---|
MSM Protein Technologies, Inc.
 MSM Protein Technologies, Inc. Pharmaceuticals: MajorHealth Technology MSM Protein Technologies is an early drug development company that specializes in antibody drug discovery against integral membrane proteins. MSM Protein Technologies is based in Waltham, MA and was founded in 2005 by Davis Farmer, Eldar Kim, and David Kreimer. The private company has a solid record of successful partnerships with big pharma companies in drug discovery and development programs. The company's pipeline includes a number of first-in-class pre-clinical stage antibodies targeting several GPCRs, mainly focused on immunologic and oncologic diseases such as blood cancers, solid tumors, autoimmune diseases, and respiratory diseases. | Director/Board Member | 2004-12-31 | - |
| Chief Operating Officer | 2004-12-31 | - | |
| Founder | 2004-12-31 | - | |
| President | 2004-12-31 | - |
Career history of David Kreimer
Statistics
International
| United States | 2 |
Operational
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
MSM Protein Technologies, Inc.
MSM Protein Technologies, Inc. Pharmaceuticals: MajorHealth Technology MSM Protein Technologies is an early drug development company that specializes in antibody drug discovery against integral membrane proteins. MSM Protein Technologies is based in Waltham, MA and was founded in 2005 by Davis Farmer, Eldar Kim, and David Kreimer. The private company has a solid record of successful partnerships with big pharma companies in drug discovery and development programs. The company's pipeline includes a number of first-in-class pre-clinical stage antibodies targeting several GPCRs, mainly focused on immunologic and oncologic diseases such as blood cancers, solid tumors, autoimmune diseases, and respiratory diseases. | Health Technology |
- Stock Market
- Insiders
- David Kreimer
- Experience
